Novo Nordisk, Lilly and White House
Digest more
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...
Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation over board composition. Key board members, including Chair Helge Lund, will ...
Operating profit increased by 5% in Danish kroner and 10% at constant exchange rates (CER) to DKK 95.9 billion, impacted by one-off restructuring costs of around DKK 9 billion related to the ...
Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...
Novo Nordisk's board changes stem from disagreements with the Novo Nordisk Foundation over board composition and strategic ...
Novo Nordisk NVO saw 18% sales growth and 40% operating profit growth at constant currencies in the second quarter, but management reduced 2025 guidance to 8%-14% sales growth and 10%-16% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback